JPH07222599A - Method for measuring antimicrobial activity of medicine - Google Patents

Method for measuring antimicrobial activity of medicine

Info

Publication number
JPH07222599A
JPH07222599A JP1648594A JP1648594A JPH07222599A JP H07222599 A JPH07222599 A JP H07222599A JP 1648594 A JP1648594 A JP 1648594A JP 1648594 A JP1648594 A JP 1648594A JP H07222599 A JPH07222599 A JP H07222599A
Authority
JP
Japan
Prior art keywords
atp
amount
drug
antimicrobial activity
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1648594A
Other languages
Japanese (ja)
Inventor
Shinichi Yaginuma
真一 柳沼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Ink Mfg Co Ltd
Original Assignee
Toyo Ink Mfg Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Ink Mfg Co Ltd filed Critical Toyo Ink Mfg Co Ltd
Priority to JP1648594A priority Critical patent/JPH07222599A/en
Publication of JPH07222599A publication Critical patent/JPH07222599A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE:To rapidly and simply measure the antimicrobial activity of a medicine such as an antibiotic substance by inoculating a microorganism to be tested into a liquid culture medium containing the medicine, culturing the microorganism for a prescribed time, then measuring the amount of adenosine triphosphate(ATP) in the microbial cell thereof and comparing the resultant amount with the control amount of the ATP. CONSTITUTION:This method for measuring the antimicrobial activity of a medicine is to distribute a liquid culture medium such as a potato dextrose agar(PDA) culture medium containing a medicine such as an antibiotic substance, an antimicrobial agent or an antifungal agent into a microtiter plate, etc., then aseptically inoculate a microorganism to be tested thereinto, culture the microorganism at 25-37 deg.C for a prescribed time, subsequently add an extracting agent for ATP, extract the ATP in the microbial cell thereof, add luciferin-luciferase thereto, measure the luminous quantity, measure the amount of the ATP and compare the resultant amount of the ATP with the amount of the ATP which is the control obtained in the culture medium without containing the medicine. Thereby, the antimicrobial activity of the medicine can rapidly and simply be measured.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、抗生物質などの薬剤の
抗微生物活性の測定法に関するものである。
FIELD OF THE INVENTION The present invention relates to a method for measuring the antimicrobial activity of drugs such as antibiotics.

【0002】[0002]

【従来の技術】抗菌化学療法における薬剤の抗微生物活
性測定の最大の目的は、感染症の治療に有効な抗菌剤等
を短時間で正確に選択することにある。すなわち、正確
に検出した原因菌にどの薬剤が抗菌作用を示すか、また
どの程度の抗菌力があるかを測定することであり、正確
さと同時に迅速性が要求される。一方、分離された細菌
の薬剤の抗微生物活性の成績から、各菌種の感受性パタ
ーンの推移を知るための疫学的調査にも応用されてい
る。現在用いられている薬剤の抗微生物活性測定法は拡
散法と希釈法に大別される。拡散法としては迅速性、簡
便性を目標にした薬剤含有ディスクを用いるディスク法
が広く使用されている。
2. Description of the Related Art The greatest purpose of measuring the antimicrobial activity of a drug in antibacterial chemotherapy is to accurately select an antibacterial drug or the like effective for treating infectious diseases in a short time. That is, it is to measure which drug exhibits an antibacterial action and the degree of antibacterial activity of the accurately detected causative bacterium, and accuracy and promptness are required. On the other hand, it is also applied to an epidemiological study to know the transition of the susceptibility pattern of each bacterial species based on the antimicrobial activity of the isolated bacterial drug. Currently used methods for measuring the antimicrobial activity of drugs are roughly classified into the diffusion method and the dilution method. As a diffusion method, a disk method using a drug-containing disk aiming at quickness and simplicity is widely used.

【0003】ディスク法は細菌などの微生物の薬剤抗微
生物活性を調べる方法のうちで、もっとも簡便化された
ものである。この方法は、ディスクに含まれた薬剤が培
地の水分で溶解され、菌を接種した寒天培地中に拡散す
る性質を利用している。薬剤はディスクの真下の寒天層
から始まり、周囲に向かって拡散される。このため、培
地中に薬剤の濃度勾配ができ、当然、ディスクに近い培
地中の薬剤濃度は濃く、遠い場所は薄くなる。培地平板
上に接種した菌の薬剤に対する感受性の差により、ディ
スクの周辺に菌の発育が認められない阻止円が形成され
る。
The disk method is the simplest of the methods for examining the drug antimicrobial activity of microorganisms such as bacteria. This method utilizes the property that the drug contained in the disk is dissolved by the water content of the medium and diffuses into the agar medium inoculated with the bacterium. The drug begins in the agar layer beneath the disc and is diffused towards the surroundings. For this reason, a concentration gradient of the drug is formed in the medium, and naturally, the drug concentration in the medium near the disc is high and the distance is thin. Due to the difference in the susceptibility of the bacteria inoculated on the medium plate to the drug, an inhibition circle is formed around the disc where no growth of the bacteria is observed.

【0004】希釈法には寒天平板希釈法と液体培地希釈
法とがあり、いずれも定量的に最小発育阻止濃度(Mi
nimum Inhibitory Concentr
ation:MIC)を求めるものである。寒天平板希
釈法は、感受性測定用培地としてMuller−Hin
ton培地を基礎とした半合成培地(MH培地)を使用
する。薬剤の2倍希釈系列を作り、MH培地の温度が6
0℃くらいの時に、薬液と培地をシャーレの中で混ぜ合
わせ、薬剤含有寒天平板を作成する。この平板上に被検
菌の一夜培養液またはその希釈液を一定量塗沫接種す
る。37℃で18〜20時間培養した後、発育の有無を
測定し、対照培地と比較して増殖が完全に阻止された最
小濃度をMICとして評価する。
The dilution method includes an agar plate dilution method and a liquid medium dilution method, both of which quantitatively have a minimum inhibitory concentration (Mi
nimum Inhibitory Concentr
ation: MIC). The agar plate dilution method uses Muller-Hin as a medium for sensitivity measurement.
A semi-synthetic medium (MH medium) based on ton medium is used. Make a 2-fold dilution series of the drug and keep the MH medium at a temperature of 6
At about 0 ° C, the drug solution and the medium are mixed in a petri dish to prepare a drug-containing agar plate. A certain amount of the overnight culture solution of the test bacteria or a diluted solution thereof is spread and inoculated on this plate. After culturing at 37 ° C. for 18 to 20 hours, the presence or absence of growth is measured, and the minimum concentration at which the growth is completely inhibited as compared with the control medium is evaluated as MIC.

【0005】液体培地希釈法は、液体培地によって薬剤
を希釈し、被検菌を接種、その菌に対するMICを求め
る方法である。一般的な方法は、96穴マイクロタイタ
ープレートに感受性測定用培地(CSMH培地)で希釈
した薬液を無菌的に分注し、そこに被検菌の一夜培養液
またはその希釈液を一定量接種したものを35±1℃で
18〜24時間培養し、対照に用いた薬剤不含有培地で
の発育を確認した後、菌の発育が肉眼的に認められない
ウェルの、最小の薬剤濃度を以てMICとして評価す
る。これら現行の方法は、全て微生物細胞の増殖を直接
観察して判定するものである。つまり、微生物細胞の増
殖をどの程度阻害し、細胞数をどの程度減少させること
ができるか観察して抗微生物活性として判定するもので
あり、結果を得るまでに約2〜5日程度の日数を要す
る。従って、被検菌の培養時間も含めると、検査の依頼
を受けてから、少なくとも約2日以上経過しなければ結
果を知ることが出来ない。
The liquid medium dilution method is a method in which a drug is diluted with a liquid medium, a test bacterium is inoculated, and the MIC for the bacterium is determined. As a general method, a 96-well microtiter plate is aseptically dispensed with a drug solution diluted with a susceptibility measurement medium (CSMH medium), and a certain amount of an overnight culture solution of the test bacterium or a diluted solution thereof is inoculated therein. After culturing the cells at 35 ± 1 ° C. for 18 to 24 hours and confirming the growth in the drug-free medium used as a control, the MIC was determined with the minimum drug concentration in the wells in which the growth of bacteria was not visually recognized. evaluate. In all of these current methods, the growth of microbial cells is directly observed and determined. That is, it is determined as an antimicrobial activity by observing how much the growth of microbial cells can be inhibited and how much the number of cells can be reduced, and it takes about 2 to 5 days to obtain the results. It costs. Therefore, including the culture time of the test bacterium, the result cannot be known until at least about two days have passed since the request for the test was received.

【0006】一方、アデノシン三リン酸(ATP)は細
胞体内に存在するヌクレオチドの1種であり、数多くの
エネルギー代謝に関与して、エネルギーの獲得および利
用に重要な役割を果たす化合物である。微生物細胞のA
TP量は主に生物発光測定法により測定できることが知
られている。例えば、ホタル由来のルシフェリン−ルシ
フェラーゼ系を用いる発光測定法において、特定の界面
活性剤を含有させると体細胞と微生物細胞の混合物から
選択的に微生物のATP量を、細胞壁や細胞膜を破壊す
ることなく測定できることが知られているが、これら公
知の微生物のATP量測定方法を薬剤抗微生物活性の判
定に応用する技術は実用化されていない。
On the other hand, adenosine triphosphate (ATP) is one of the nucleotides existing in the cell body, and is a compound that is involved in many energy metabolisms and plays an important role in energy acquisition and utilization. A of microbial cells
It is known that the amount of TP can be measured mainly by a bioluminescence measuring method. For example, in a luminescence measurement method using a firefly-derived luciferin-luciferase system, when a specific surfactant is contained, the ATP amount of the microorganism is selectively selected from a mixture of somatic cells and microbial cells without destroying the cell wall or cell membrane. It is known that it can be measured, but the technique of applying these known methods for measuring the ATP amount of microorganisms to the determination of drug antimicrobial activity has not been put into practical use.

【0007】[0007]

【発明が解決しようとする課題】従って、本発明が解決
しようとする課題は、微生物のATP量を測定して、判
定までに細菌や酵母の場合は1〜2日を要し、カビでは
3〜7日を要している現行法による薬剤抗微生物活性試
験法よりも、簡便かつ短時間で実施できる手段を提供す
ることにある。
Therefore, the problem to be solved by the present invention is that it takes 1-2 days for bacteria or yeasts to measure the ATP amount of microorganisms, and 3 for molds. It is to provide a means which can be carried out more simply and in a shorter time than the drug antimicrobial activity test method according to the current method, which requires ~ 7 days.

【0008】[0008]

【課題を解決するための手段】本発明者らは、活性微生
物中のATP量の増減が、その微生物の生育・増殖状況
と相関することに着目し、抗生物質などの薬剤を添加し
た培地に被検菌を接種して培養した後、ATP量をルシ
フェリン−ルシフェラーゼを利用して測定すると、現行
法に比べて著しく短い時間で薬剤抗微生物活性が判定で
きることを見出し、本発明を完成した。すなわち、本発
明は薬剤を含有する液体培地に、被検微生物を接種し一
定時間培養した後、微生物菌体細胞中のATP量を測定
し、このATP量と薬剤を含有しない培地によるATP
量と比較することを特徴とする薬剤の抗微生物活性測定
法を提供するものである。
[Means for Solving the Problems] The present inventors focused on the fact that the increase / decrease in the amount of ATP in active microorganisms correlates with the growth / proliferation state of the microorganisms, and the medium containing an agent such as an antibiotic was added to the medium. The present invention was completed by discovering that the drug antimicrobial activity can be determined in a significantly shorter time than the current method by measuring the amount of ATP using luciferin-luciferase after inoculating a test bacterium and culturing, and completed the present invention. That is, the present invention is that a liquid medium containing a drug is inoculated with a test microorganism and cultured for a certain period of time, and then the amount of ATP in microbial somatic cells is measured.
The present invention provides a method for measuring the antimicrobial activity of a drug, which is characterized by comparing with the amount.

【0009】ATPは、活性微生物細胞中で嫌気的代謝
における解糖や発酵、あるいは好気的代謝における酸化
的リン酸化反応などによって生産されるものであり、細
胞中のATP量は、活性微生物細胞では増殖に伴い増加
し、抗生物質等の薬剤で不活性化あるいは死活化された
細胞ではATPの生産は止まり、あるいは細胞内で消費
されて減少していく。従って、薬剤を添加した培地に被
検菌を接種し培養した時のATP量を、薬剤を添加しな
い培地に同一濃度で接種した被検菌の培養開始直後に測
定したATP量と比較すれば、その薬剤の対象微生物へ
の抗菌活性の程度を知ることができる。
ATP is produced in active microbial cells by glycolysis and fermentation in anaerobic metabolism, or by oxidative phosphorylation in aerobic metabolism, and the amount of ATP in the cells is the amount of active microbial cells. Then, it increases with proliferation, and ATP production is stopped in cells inactivated or killed by drugs such as antibiotics, or it is consumed in the cells and decreased. Therefore, if the ATP amount when the test bacterium is inoculated and cultured in the medium to which the drug is added is compared with the ATP amount measured immediately after the start of the culture of the test bacterium inoculated to the medium without the drug at the same concentration, The degree of antibacterial activity of the drug against the target microorganism can be known.

【0010】本発明では、被検菌体のATP量の測定
は、具体的にはルシフェリン(発光素)−ルシフェラー
ゼ(発光酵素)系を用い、その発光量を測定することに
より行なうことができる。ルシフェリン−ルシフェラー
ゼ系としては、発光にATPを必要とする系であればい
かなるものも利用可能である。例えば、ホタルなど公知
の系に由来するものやクローニングで得た微生物由来の
ものが利用できる。ルシフェリン−ルシフェラーゼ系を
利用してATPの発光量をカウントする試薬キットおよ
び発光量を評価(カウント)する装置は市販されてお
り、本発明方法を実施するに際してはこのような市販の
キットおよび装置を利用して被検菌体のATP量を測定
することができる。具体的には、予め常法により被検菌
を培地に培養しておき、これを所定濃度に希釈してその
ATP発光量をルシフェリン−ルシフェラーゼ系を用い
て測定し、その値を対照値とする。
In the present invention, the amount of ATP in the test bacterium can be measured specifically by using a luciferin (luminescent element) -luciferase (luminescent enzyme) system and measuring the amount of luminescence. As the luciferin-luciferase system, any system can be used as long as it requires ATP for light emission. For example, those derived from a known system such as firefly or those derived from a microorganism obtained by cloning can be used. A reagent kit for counting the amount of luminescence of ATP and a device for evaluating (counting) the amount of luminescence using the luciferin-luciferase system are commercially available, and when carrying out the method of the present invention, such a commercially available kit and device are used. The amount of ATP of the test bacterium can be measured by utilizing this. Specifically, a test bacterium is previously cultured in a medium by a conventional method, diluted to a predetermined concentration, and its ATP luminescence is measured using a luciferin-luciferase system, and the value is used as a control value. .

【0011】しかしながら、常法により得られた培地で
は、測定に悪影響を及ぼす非微生物由来のATPが相当
量含有されているため、抗微生物活性の高感度かつ正確
な測定が困難であった。従って、本発明では、ATPを
実質的に含有しない培地、例えばLB培地やATP除去
処理(ATP分解酵素により、分解・除去)を施したP
DA培地が好ましい。一方、評価試験に供する薬剤を所
定濃度に調整した薬剤含有測定用培地を、マイクロタイ
タープレートに所定量ずつ分注する。ついで、前培養し
た上記被検菌液を生理食塩水などで所定濃度(102
FU/well〜2×106 CFU/well)に希釈
し、前記薬剤含有測定用培地の各ウェルに接種する。こ
のプレートを25〜37℃で所定時間(10秒〜24時
間)培養後、ATP抽出剤を添加しATPを抽出した
後、ルシフェリン−ルシフェラーゼを所定量添加し、そ
の発光量を測定する。この測定値を前記対照の値と比較
して、ATP量の減少が顕著な濃度をMICまたはMB
Cとする。つまり、濃度を変えて測定することによりA
TP量の減少が顕著な薬剤濃度をもって、MICまたは
MBCとするものである。
However, since the medium obtained by the conventional method contains a considerable amount of non-microbial-derived ATP, which has a bad influence on the measurement, it is difficult to measure the antimicrobial activity with high sensitivity and accuracy. Therefore, in the present invention, a medium that does not substantially contain ATP, such as LB medium, or P that has been subjected to ATP removal treatment (decomposition / removal with an ATP-degrading enzyme)
DA medium is preferred. On the other hand, the drug-containing measurement medium in which the drug to be used in the evaluation test is adjusted to a predetermined concentration is dispensed into the microtiter plate in a predetermined amount. Then, the pre-cultured test bacterial solution was washed with physiological saline or the like at a predetermined concentration (10 2 C).
FU / well to 2 × 10 6 CFU / well) and inoculate each well of the drug-containing measurement medium. After culturing this plate at 25 to 37 ° C. for a predetermined time (10 seconds to 24 hours), an ATP extractant is added to extract ATP, and then a predetermined amount of luciferin-luciferase is added, and the luminescence amount thereof is measured. This measured value was compared with that of the control, and the concentration at which the decrease in ATP amount was remarkable was determined to be MIC or MB.
Let be C. In other words, by changing the concentration and measuring
MIC or MBC is defined as the drug concentration at which the decrease in TP amount is remarkable.

【0012】さらに、培養時間を変えて、ATP量を測
定することにより、薬剤の抗微生物活性を知ることもで
きる。抗真菌剤の場合は、10秒〜1時間程度で判定で
き、酵母では1〜6時間、カビでは10〜24時間で判
定できる。
Further, the antimicrobial activity of the drug can be known by changing the culture time and measuring the amount of ATP. In the case of an antifungal agent, it can be judged in about 10 seconds to 1 hour, in yeast it can be judged in 1 to 6 hours, and in mold it can be judged in 10 to 24 hours.

【0013】[0013]

【発明の効果】本発明の方法によれば、従来、判定まで
に少なくとも約1日の培養時間を要し、肉眼観察あるい
は吸光度の測定などにより行なわれていた薬剤抗微生物
活性測定を、短時間で、しかも発光量を機械的にカウン
トして容易に実施することができる。また、従来法、例
えば、吸光度を測定して判定する方法などでは生菌だけ
でなく死菌も判定してしまうため測定データに誤差を含
むが、本発明の方法では、原理的に生菌のATPを測定
するので薬剤抗微生物活性試験の精度が高いという特徴
がある。従って、本発明の方法は薬剤抗微生物活性のみ
ならず、感染症治療において薬剤の感受性試験法として
も大きなメリットをもたらすものである。
EFFECTS OF THE INVENTION According to the method of the present invention, at least about 1 day of culture time is required until the determination, and the drug antimicrobial activity measurement which has been performed by visual observation or measurement of absorbance can be performed in a short time. Moreover, the amount of light emission can be mechanically counted and easily implemented. Further, in the conventional method, for example, in the method of determining by measuring the absorbance, the measurement data contains an error because not only live cells but also dead cells are determined, but in the method of the present invention, in principle, Since ATP is measured, the drug antimicrobial activity test is characterized by high accuracy. Therefore, the method of the present invention brings great advantages not only as a drug antimicrobial activity but also as a drug susceptibility test method in the treatment of infectious diseases.

【0014】[0014]

【実施例】【Example】

実施例1 本試験において、ATP量を測定する被検菌として、C
andida albicans ATCC10231
株を使用した。この被検菌の一白金耳量を真菌用標準P
DA接地プレートに接種し、35℃、24時間静置培養
した。ATP量測定による抗微生物活性測定として、下
記の測定用培地を使用した。なお,下記組成は培地1リ
ットル中における組成を示す。 トリプトン 5g 酵母エキス 3g 食塩 1g 上記測定用培地に、抗真菌剤として、Amphoter
icin BおよびBenzalkonium chl
orideを、濃度を段階的に変えた抗真菌剤含有測定
用培地を96穴マイクロタイタープレート(Dynal
ech社製:白色)に、1ウェルあたり100±10μ
lずつ分注した。
Example 1 In this test, C was used as a test bacterium for measuring the amount of ATP.
andida albicans ATCC10231
Strains were used. One platinum loop amount of this test bacterium is the standard P for fungi
A DA ground plate was inoculated and statically cultured at 35 ° C. for 24 hours. The following measuring medium was used for measuring the antimicrobial activity by measuring the amount of ATP. The following composition indicates the composition in 1 liter of medium. Tryptone 5 g Yeast extract 3 g Salt 1 g The above measurement medium was supplemented with Amphoter as an antifungal agent.
icin B and Benzalkonium chl
Oride was added to a 96-well microtiter plate (Dynal
ech: white), 100 ± 10μ per well
It was dispensed in liters.

【0015】次に、前培養した上記被検菌液(2×10
6 CFU/ml)を生理食塩水で100倍に希釈し、マ
イクロタイタープレートの各ウェルに10μlずつ無菌
的に接種した。このプレートを35℃で6時間培養後、
ATP抽出剤(商品名:菌士郎ATP抗菌テストキッ
ト,東洋インキ製造社製)を100μlを添加しATP
を抽出した後、ホタル由来のルシフェリン−ルシフェラ
ーゼ(商品名:菌士郎ATP抗菌テストキット)100
μlを加えた。ルーマットLB9501(ベルトールド
社製)を用い、積算時間10秒で発光量を測定した。被
検菌液(2×10 6 CFU/ml)を生理食塩水で10
0倍に希釈した10μlについて、同じくATP抽出
剤、ルシフェリン−ルシフェラーゼを加え、発光量を測
定し、ブランク値(対照)とした。測定結果を図1およ
び図2に示す。
Next, the pre-cultured test bacterial solution (2 × 10
6CFU / ml) diluted 100 times with physiological saline,
Aseptic 10 μl in each well of the icrotiter plate
Vaccination. After incubating this plate at 35 ° C for 6 hours,
ATP extractant (Brand name: Shiro Shiro ATP antibacterial test kit
ATP manufactured by Toyo Ink Mfg. Co., Ltd.
Luciferin derived from firefly-lucifera
(Product name: Bushiro ATP Antibacterial Test Kit) 100
μl was added. Lumat LB9501 (Beltold
(Manufactured by the same company) was used to measure the amount of light emission at an integration time of 10 seconds. Cover
Test liquid (2 x 10 6CFU / ml) with saline 10
ATP extraction was also performed on 10 μl diluted 0 times.
Agent, luciferin-luciferase, and measure the amount of luminescence.
Was set as a blank value (control). The measurement results are shown in Fig. 1 and
And shown in FIG.

【0016】抑制率の算出として、以下の式を用いた。 〔(ブランク値−各抗真菌剤濃度における発光量)/ブ
ランク値〕×100 一方、発光量測定サンプルの生菌数(CFU)を従来の
標準寒天培地により35℃,48時間培養によりカウン
トした結果もあわせて図1および図2に抑制率として示
す。なお,各図において,縦軸は抑制率(%),横軸は
薬剤濃度を示す。図1および図2から、本測定法が従来
法である標準寒天培養法と高い相関性を持ち、十分実用
性があることが判る。又、抑制率の急激な低下からMI
Cが定量的に判定できる。なお、この判定は熟練者によ
る目視判定を必要とせず、誰でも簡便に測定できる。 実施例2 〔被検菌の前培養〕本試験においては、ATP量を測定
する被検菌としてEscherichiacoli N
IHJ株を使用した。この被検菌(Escherich
ia coli NIHJ株)の一白金耳量を下記組成
の前培養液培地5mlに無菌的に接種し、35℃,20
時間静置培養した。 〔前培養用培地(Muller−Hinton Bro
th)〕 牛肉注出液 300 g カザミノ酸 17.5g でんぷん 1.5g 精製水 1000 ml pH7.2〜7.4(25℃:滅菌後) 〔ATP量測定による抗微生物活性試験法〕測定用培地
として下記の組成の培地を使用した。
The following equation was used to calculate the inhibition rate. [(Blank value-Amount of luminescence at each antifungal agent concentration) / Blank value] x 100 On the other hand, the result of counting the viable cell count (CFU) of the luminescence measurement sample by culturing at 35 ° C for 48 hours on a conventional standard agar medium The suppression rate is also shown in FIGS. 1 and 2. In each figure, the vertical axis represents the inhibition rate (%) and the horizontal axis represents the drug concentration. From FIG. 1 and FIG. 2, it can be seen that this measuring method has a high correlation with the conventional standard agar culture method and is sufficiently practical. In addition, because the suppression rate drops sharply, MI
C can be quantitatively determined. It should be noted that this determination does not require a visual determination by a skilled person, and anyone can easily perform the measurement. Example 2 [Preculture of test bacterium] In this test, Escherichia coli N was used as a test bacterium for measuring the amount of ATP.
The IHJ strain was used. This test bacteria (Escherich
IA coli NIHJ strain) in an amount of 1 platinum loop is aseptically inoculated into 5 ml of the preculture medium having the following composition,
The culture was allowed to stand for a period of time. [Preculture medium (Muller-Hinton Bro
th)] Beef pouring solution 300 g Casamino acid 17.5 g Starch 1.5 g Purified water 1000 ml pH 7.2 to 7.4 (25 ° C: after sterilization) [Antimicrobial activity test method by ATP amount measurement] Measurement medium As the medium, the medium having the following composition was used.

【0017】測定用培地(Cation Supple
mented Muller−Hinton Brot
h) 牛肉抽出液 300 g カザミノ酸 17.5g でんぷん 1.5g 精製水 1000 ml pH7.2〜7.4(25℃:滅菌後) Caイオン* 50mg/l Mgイオン* 25mg/l *滅菌後無菌的に添加した。
Measurement medium (Cation Supple
Mented Muller-Hinton Brot
h) Beef extract 300 g Casamino acid 17.5 g Starch 1.5 g Purified water 1000 ml pH 7.2 to 7.4 (25 ° C .: after sterilization) Ca ion * 50 mg / l Mg ion * 25 mg / l * Sterile after sterilization Was added.

【0018】上記測定用培地に、下記表1に示す試験の
対象となる各種抗生物質を所定の濃度に調整した抗生物
質含有測定用培地を、96穴マイクロタイタープレート
(住友化学工業社製:白色)に、1ウェルあたり100
±10μlずつ分注した。対象抗生物質名と試験濃度の
ほか現行法(液体培地希釈法)により予め求めたMIC
をも表1に示す。なお、試験濃度としては、MICを含
む範囲の2点を選択した。 次に、前培養した上記被検菌液(2×108 CFU/m
l)を生理食塩水で100倍に希釈し、マイクロタイタ
ープレートの各ウェルに5μlずつ無菌的に接種した
(104 CFU/well)。このプレートを35℃で
4時間培養後、ATP放出剤(商品名:PICOEX
B:パッカードジャパン社製)を100μlを添加しA
TPを抽出した後、ホタル由来のルシフェリン−ルシフ
ェラーゼ(商品名:Pycozyme:パッカードジャ
パン社製)40μlを加えた。Luminos CT−
9000(中央科学工業株式会社製)を用い、電圧10
50V、積算時間1.0秒で発光量を測定した。被検菌
液(2×108 CFU/ml)を生理食塩水で100倍
に希釈した5μlについて、同じくATP抽出剤,ルシ
フェリン−ルシフェラーゼを加え、発光量を測定し、ブ
ランク値(対照)とした。測定結果を表2に示す。 本試験では4時間培養後のATP量の発光量を測定して
ATP量の減少が顕著なものを抗菌活性が高いと判定で
きる。
A 96-well microtiter plate (manufactured by Sumitomo Chemical Co., Ltd .: white) was added to the above-mentioned measuring medium, and the measuring medium containing various antibiotics to be tested shown in Table 1 below was adjusted to a predetermined concentration. ), 100 per well
Aliquots of ± 10 μl were dispensed. MIC determined in advance by the current method (liquid medium dilution method) in addition to the target antibiotic name and test concentration
Is also shown in Table 1. As the test concentration, two points within the range including MIC were selected. Then, the pre-cultured test bacterial solution (2 × 10 8 CFU / m 2
1) was diluted 100 times with physiological saline, and 5 μl of each well of the microtiter plate was aseptically inoculated (10 4 CFU / well). After culturing the plate at 35 ° C for 4 hours, the ATP releasing agent (trade name: PICOEX
B: manufactured by Packard Japan Co., Ltd.)
After extracting TP, 40 μl of firefly-derived luciferin-luciferase (trade name: Pycozyme: manufactured by Packard Japan) was added. Luminos CT-
Using 9000 (Chuo Kagaku Kogyo Co., Ltd.), voltage 10
The amount of light emission was measured at 50 V and an integration time of 1.0 second. A test extract (2 × 10 8 CFU / ml) was diluted 100 times with physiological saline, and 5 μl of the same was added with the ATP extractant, luciferin-luciferase, and the amount of luminescence was measured to obtain a blank value (control). . The measurement results are shown in Table 2. In the present test, the amount of luminescence of the ATP amount after culturing for 4 hours was measured, and it can be determined that the antibacterial activity is high when the decrease in the ATP amount is remarkable.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明法による6時間後のATP量測定結果を
示すグラフである。
FIG. 1 is a graph showing the results of measuring the amount of ATP after 6 hours by the method of the present invention.

【図2】現行法による20時間後の吸光度による薬剤の
抗微生物活性試験の結果を示すグラフである。
FIG. 2 is a graph showing the results of an antimicrobial activity test of a drug based on the absorbance after 20 hours according to the current method.

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】 薬剤を含有する液体培地に、被検微生物
を接種し一定時間培養した後、微生物菌体細胞中のAT
P量を測定し、このATP量と薬剤を含有しない培地に
よる対照のATP量と比較することを特徴とする薬剤の
抗微生物活性測定法。
1. An AT in a microbial cell after inoculating a test microorganism into a liquid medium containing a drug and culturing for a certain period of time.
A method for measuring antimicrobial activity of a drug, which comprises measuring the amount of P and comparing the amount of ATP with the amount of ATP of a control in a medium containing no drug.
【請求項2】 上記培地が、ATPを実質的に含有しな
い培地または予じめATP除去処理を施した培地を用い
る請求項1記載の薬剤の抗微生物活性測定法。
2. The method for measuring the antimicrobial activity of a drug according to claim 1, wherein the medium is a medium which does not substantially contain ATP or a medium which has been subjected to a preliminary ATP removal treatment.
【請求項3】 ルシフェリン−ルシフェラーゼを用いて
ATP量を測定する請求項1または2記載の薬剤の抗微
生物活性測定法。
3. The method for measuring the antimicrobial activity of a drug according to claim 1 or 2, wherein the amount of ATP is measured using luciferin-luciferase.
【請求項4】 薬剤を含有する測定用培地をマイクロタ
イタープレートに分注した後、被検微生物を無菌的に接
種し、25〜37℃で10秒〜24時間培養後、ATP
抽出剤を添加し、ルシフェリン−ルシフェラーゼを加え
て発光量を測定する請求項1〜3いずれか記載の薬剤の
抗微生物活性測定法。
4. A measurement medium containing a drug is dispensed into a microtiter plate, and then a test microorganism is aseptically inoculated and cultured at 25 to 37 ° C. for 10 seconds to 24 hours, followed by ATP.
The method for measuring the antimicrobial activity of a drug according to any one of claims 1 to 3, wherein an extractant is added, and luciferin-luciferase is added to measure the amount of luminescence.
【請求項5】 薬剤が抗生物質、抗菌剤および抗真菌剤
から選ばれる少くなくとも1種である請求項1〜4いず
れか記載の薬剤の抗微生物活性測定法。
5. The method for measuring the antimicrobial activity of a drug according to claim 1, wherein the drug is at least one selected from antibiotics, antibacterial agents and antifungal agents.
【請求項6】 薬剤の抗微生物活性測定が、最小発育阻
止濃度(MIC)または最小殺菌濃度(MBC)である
請求項1〜5いずれか記載の薬剤の抗微生物活性測定
法。
6. The method for measuring the antimicrobial activity of a drug according to any one of claims 1 to 5, wherein the antimicrobial activity measurement of the drug is a minimum inhibitory concentration (MIC) or a minimum bactericidal concentration (MBC).
【請求項7】 液体培地がポテトデキストロースアガー
(PDA)培地である請求項1〜6いずれか記載の薬剤
の抗微生物活性測定法。
7. The method for measuring the antimicrobial activity of a drug according to claim 1, wherein the liquid medium is a potato dextrose agar (PDA) medium.
JP1648594A 1994-02-10 1994-02-10 Method for measuring antimicrobial activity of medicine Pending JPH07222599A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1648594A JPH07222599A (en) 1994-02-10 1994-02-10 Method for measuring antimicrobial activity of medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1648594A JPH07222599A (en) 1994-02-10 1994-02-10 Method for measuring antimicrobial activity of medicine

Publications (1)

Publication Number Publication Date
JPH07222599A true JPH07222599A (en) 1995-08-22

Family

ID=11917591

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1648594A Pending JPH07222599A (en) 1994-02-10 1994-02-10 Method for measuring antimicrobial activity of medicine

Country Status (1)

Country Link
JP (1) JPH07222599A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019108125A1 (en) * 2017-11-30 2019-06-06 Ascilion Ab A method for determining microbial susceptibility to antibiotic agents
CN110272963A (en) * 2019-03-15 2019-09-24 李文杰 ATP bioluminescence lgCA-lgIAThe method of calibration curve method evaluation chemical product fungi killing effect
CN110272975A (en) * 2019-03-15 2019-09-24 李文杰 ATP bioluminescence lgCB-lgIBThe method of calibration curve method evaluation chemical product fungi killing effect

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019108125A1 (en) * 2017-11-30 2019-06-06 Ascilion Ab A method for determining microbial susceptibility to antibiotic agents
CN110272963A (en) * 2019-03-15 2019-09-24 李文杰 ATP bioluminescence lgCA-lgIAThe method of calibration curve method evaluation chemical product fungi killing effect
CN110272975A (en) * 2019-03-15 2019-09-24 李文杰 ATP bioluminescence lgCB-lgIBThe method of calibration curve method evaluation chemical product fungi killing effect

Similar Documents

Publication Publication Date Title
US4014745A (en) Application of luciferase assay for ATP to antimicrobial drug susceptibility
US20080166753A1 (en) Microbial Growth Assay
US6046021A (en) Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a multiwell testing device
JPH074272B2 (en) Specific medium for detecting microorganisms
US9057093B2 (en) Detection and enumeration of microorganisms
US5523214A (en) Method of visually demonstrating the presence of microorganisms, identifying them, and testing them for sensitivity to antibiotics with redox indicators
US9290789B2 (en) Method for measuring cells, and reagent for cell measurement
BG61400B1 (en) Means for detecting residual quantities of bactericidal compounds in liquids
EP2331702B1 (en) Culture medium enabling the differentiation of staphylococcus aureus from coagulase-negative staphylococci
US4026767A (en) Test procedure for microorganisms in blood
JPH07222599A (en) Method for measuring antimicrobial activity of medicine
WO2000031292A1 (en) Method for counting living cells
EP0789779A2 (en) Medium for detecting target microbes in a sample
Harber et al. A new method for antibiotic assay based on measurement of bacterial adenosine triphosphate using the firefly bioluminescence system
RU2660567C1 (en) Method for isolation and identification of bacteria of acinetobacter calcoaceticus - acinetobacter baumannii complex
CA2140703A1 (en) Biotest
JPH04370100A (en) Method for examining sensitivity of microorganism to drug
Gümüş et al. The Possible effects of different hormones on growth rate and ability of biofilm formation in different types of microorganisms
US20040110247A1 (en) New molecular tools for the rapid assessment of the presence and viability of microorganisms and methods of use
EP4114962A1 (en) Luciferase-based methods for detecting bacterial and fungal cells and assessing susceptibility of bacterial cells to antibiotics
WO1999041408A1 (en) Microbial assay
Brady et al. Comparative evaluation of 2, 3-bis [2-methyloxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide (XTT) and 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2, 4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-8) rapid colorimetric assays for antimicrobial susceptibility testing of staphylococci and ESBL-producing clinical isolates
Tekebayeva et al. Selection of active microorganism strains isolated from a naturally salty lake for the investigation of different microbial potentials. Sustainability. 2023; 15 (1): 51
Barton A rapid bioluminescent method for the detection of methicillin-resistant Staphylococcus aureus colonies
JPH05227992A (en) Medium for bacterial cell culture